{"id":"https://openalex.org/W2887965682","doi":"https://doi.org/10.1158/1538-7445.am2018-2957","title":"Abstract 2957: Sequential transcriptomic and phosphorylation landscape of acute myelogenous leukemia (AML) on the single-cell level","display_name":"Abstract 2957: Sequential transcriptomic and phosphorylation landscape of acute myelogenous leukemia (AML) on the single-cell level","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2887965682","doi":"https://doi.org/10.1158/1538-7445.am2018-2957","mag":"2887965682"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-2957","doi":"https://doi.org/10.1158/1538-7445.am2018-2957","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-2957","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062376578","display_name":"Victoria E. H. Wang","orcid":"https://orcid.org/0000-0001-9052-3531","observed_orcids":["https://orcid.org/0000-0001-9052-3531"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victoria E. Wang","raw_affiliation_strings":["1UCSF, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCSF, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029064938","display_name":"Graham Heimberg","orcid":"https://orcid.org/0009-0002-6493-5721","observed_orcids":["https://orcid.org/0009-0002-6493-5721"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Graham Heimberg","raw_affiliation_strings":["1UCSF, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCSF, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024815439","display_name":"Gregory K. Behbehani","orcid":"https://orcid.org/0000-0002-9493-3607","observed_orcids":["https://orcid.org/0000-0002-9493-3607"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory K. Behbehani","raw_affiliation_strings":["2Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005819504","display_name":"Chun Ye","orcid":"https://orcid.org/0000-0001-6560-3783","observed_orcids":["https://orcid.org/0000-0001-6560-3783"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chun Ye","raw_affiliation_strings":["1UCSF, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCSF, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068715900","display_name":"Charalambos Babis Andreadis","orcid":"https://orcid.org/0000-0003-4681-6227","observed_orcids":["https://orcid.org/0000-0003-4681-6227"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charalambos Babis Andreadis","raw_affiliation_strings":["1UCSF, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCSF, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"2957","last_page":"2957"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11289","display_name":"Single-cell and spatial transcriptomics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.949999988079071},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.8740000128746033},{"id":"https://openalex.org/keywords/high-dose-cytarabine","display_name":"high-dose cytarabine","score":0.9330000281333923},{"id":"https://openalex.org/keywords/single-cell-rna-sequencing","display_name":"single-cell RNA sequencing","score":0.8199999928474426},{"id":"https://openalex.org/keywords/mass-cytometry","display_name":"mass cytometry","score":0.9419999718666077},{"id":"https://openalex.org/keywords/transcriptomic-landscape","display_name":"transcriptional landscape","score":0.41600000858306885},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6240000128746033},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.38499999046325684},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.5860000252723694},{"id":"https://openalex.org/keywords/on-target-effects","display_name":"on-target effects","score":0.35899999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7431104779243469},{"id":"https://openalex.org/C2777198975","wikidata":"https://www.wikidata.org/wiki/Q5134875","display_name":"Clofarabine","level":4,"score":0.6723646521568298},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6475335359573364},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.5796992182731628},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5025136470794678},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.48578929901123047},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.47952771186828613},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.41518640518188477},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3590465188026428},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3432471454143524},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14293619990348816},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-2957","doi":"https://doi.org/10.1158/1538-7445.am2018-2957","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-2957","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4237018690","https://openalex.org/W2892053009","https://openalex.org/W3185291790","https://openalex.org/W7108502605","https://openalex.org/W7078355092","https://openalex.org/W4405047454","https://openalex.org/W7160742961","https://openalex.org/W7113004798","https://openalex.org/W4417009093","https://openalex.org/W6989872408"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Patients":[2],"with":[3,75,81,151,307,322],"AML":[4,82],"refractory":[5,85],"to":[6,53,62,86,260,290,315,342,356,362],"induction":[7],"therapy":[8],"or":[9,88,105],"relapse":[10],"within":[11,91],"one":[12,92],"year":[13,93],"have":[14,33,89],"poor":[15],"outcomes.":[16],"Elevated":[17],"serum":[18,137],"hepatocyte":[19],"growth":[20],"factor":[21,28],"(HGF)":[22],"level":[23,404],"is":[24,97,347],"an":[25,41],"adverse":[26],"prognostic":[27],"in":[29,40,79,99,158,311,340],"AML.":[30],"Preclinical":[31],"models":[32],"shown":[34],"that":[35],"myeloid":[36,236],"blasts":[37,52],"produce":[38],"HGF":[39,70,323],"autocrine":[42],"fashion":[43],"and":[44,66,118,136,175,207,222,239,269,284,301,337,349,393],"pharmacologic":[45],"blockade":[46],"of":[47,68,94,102,124,148,156,235,249,328,396,408],"the":[48,64,69,146,168,194,208,219,223,250,329,343,358,365,369,402,409],"HGF/c-Met":[49],"axis":[50],"sensitizes":[51],"cell":[54],"death.":[55],"We":[56],"initiated":[57],"a":[58,121,131,152],"phase":[59],"I":[60],"study":[61],"assess":[63,363],"safety":[65,147],"tolerability":[67],"antibody":[71,229],"ficlatuzumab":[72],"(Fi)":[73],"combined":[74,306],"high-dose":[76],"cytarabine":[77],"(Cy)":[78],"patients":[80,161,258],"who":[83],"are":[84,138],"7+3":[87],"relapsed":[90],"induction.":[95],"Fi":[96],"given":[98],"escalated":[100],"dosing":[101],"10,":[103],"15,":[104],"20":[106],"mg/kg":[107],"for":[108,186,233,412],"4":[109],"doses":[110],"every":[111],"2":[112,125],"weeks,":[113],"starting":[114],"on":[115,127,179,401],"day":[116],"0,":[117],"Cy":[119],"at":[120,140],"fixed":[122],"dose":[123],"g/m2":[126],"days":[128],"2-7,":[129],"using":[130,170,193,214,267,274],"3x3":[132],"design.":[133],"PBMCs,":[134],"BM":[135],"collected":[139,182],"defined":[141],"times.":[142],"Preliminary":[143],"results":[144],"demonstrating":[145],"this":[149],"combination":[150],"promising":[153],"response":[154,341],"rate":[155],"44%":[157],"nine":[159],"evaluable":[160],"were":[162,203,212,265,272,320],"previously":[163],"presented.":[164],"Here":[165],"we":[166],"report":[167],"correlatives":[169],"single-cell":[171,403],"RNA":[172],"sequencing":[173,210],"(scRNAseq)":[174],"mass":[176],"cytometry":[177],"(Cy-TOF)":[178],"PBMC":[180],"specimens":[181,361],"longitudinally":[183],"during":[184,368],"treatment":[185,262,370],"twelve":[187,257],"patients.":[188],"Methods:":[189],"scRNAseq":[190,268,305],"was":[191],"conducted":[192],"10x":[195],"Genomics":[196],"Chromium":[197],"platform.":[198],"Twelve":[199],"genetically":[200],"distinct":[201,335],"samples":[202,255,271],"multiplexed":[204],"per":[205,287],"run":[206,273,280],"resulting":[209],"data":[211],"de-convoluted":[213],"individual":[215],"SNP":[216],"information":[217],"from":[218,256],"OmniExpressExome54":[220],"Array":[221],"novel":[224],"DEMUXLET":[225],"algorithm.":[226],"The":[227],"Cy-TOF":[228,296,308],"panel":[230],"included":[231],"markers":[232],"identification":[234],"blasts,":[237],"T":[238],"B":[240],"cells":[241,283],"as":[242,244],"well":[243],"intracellular":[245],"phospho-signaling":[246],"pathways":[247,319],"downstream":[248,302],"HGF/c-MET":[251],"axis.":[252],"Results:":[253],"Sixty":[254],"corresponding":[259,289,314],"different":[261],"time":[263],"points":[264],"analyzed":[266],"thirty":[270],"Cy-TOF.":[275],"On":[276],"average,":[277],"each":[278],"scRNA":[279],"captured":[281],"17-23K":[282],"19-24K":[285],"reads":[286],"cell,":[288],"approximately":[291],"1,000":[292],"unique":[293],"gene":[294],"trasncripts/cell.":[295],"identified":[297,309],"surface":[298],"phospho-MET":[299],"activation":[300],"pathways.":[303],"Conclusions:":[304],"changes":[310],"cellular":[312],"populations":[313],"treatment.":[316],"Effector":[317],"signaling":[318],"blunted":[321],"blockade,":[324],"suggesting":[325],"on-target":[326],"effect":[327],"antibody.":[330],"Each":[331],"population":[332],"also":[333],"exhibited":[334],"transcription":[336],"phosphorylation":[338,394],"profile":[339],"drugs.":[344],"Dose":[345],"expansion":[346],"ongoing":[348],"future":[350],"studies":[351],"will":[352],"apply":[353],"these":[354],"methods":[355],"analyze":[357],"bone":[359],"marrow":[360],"how":[364],"microenvironment":[366],"evolves":[367],"course.":[371],"Clinical":[372],"trial":[373],"information:":[374],"NCT02109627":[375],"Citation":[376],"Format:":[377],"Victoria":[378],"E.":[379],"Wang,":[380],"Graham":[381],"Heimberg,":[382],"Gregory":[383],"K.":[384],"Behbehani,":[385],"Chun":[386],"Ye,":[387],"Charalambos":[388],"Babis":[389],"Andreadis.":[390],"Sequential":[391],"transcriptomic":[392],"landscape":[395],"acute":[397],"myelogenous":[398],"leukemia":[399],"(AML)":[400],"[abstract].":[405],"In:":[406],"Proceedings":[407],"American":[410],"Association":[411],"Cancer":[413,426],"Research":[414],"Annual":[415],"Meeting":[416],"2018;":[417],"2018":[418],"Apr":[419],"14-18;":[420],"Chicago,":[421],"IL.":[422],"Philadelphia":[423],"(PA):":[424],"AACR;":[425],"Res":[427],"2018;78(13":[428],"Suppl):Abstract":[429],"nr":[430],"2957.":[431]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2018-08-22T00:00:00"}